Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Phaeohyphomycosis

M G Rinaldi1

  • 1Department of Pathology, University of Texas Health Science Center at San Antonio, USA.

Dermatologic Clinics
|January 1, 1996
PubMed
Summary
This summary is machine-generated.

Dematiaceous fungal infections, known as phaeohyphomycosis, are rising and require prompt diagnosis. Optimal management involves high suspicion, understanding clinical signs, and employing surgical and chemotherapeutic treatments.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correlation of susceptibility of Cryptococcus neoformans to amphotericin B with clinical outcome.

Antimicrobial agents and chemotherapy·2011
Same author

Molecular and phenotypic characterization of Phialemonium and Lecythophora isolates from clinical samples.

Journal of clinical microbiology·2011
Same author

Spectrum of clinically relevant Acremonium species in the United States.

Journal of clinical microbiology·2010
Same author

Molecular phylogeny and proposal of two new species of the emerging pathogenic fungus Saksenaea.

Journal of clinical microbiology·2010
Same author

Wild-type MIC distributions and epidemiological cutoff values for the triazoles and six Aspergillus spp. for the CLSI broth microdilution method (M38-A2 document).

Journal of clinical microbiology·2010
Same author

Comparison of 24-hour and 48-hour voriconazole MICs as determined by the Clinical and Laboratory Standards Institute broth microdilution method (M27-A3 document) in three laboratories: results obtained with 2,162 clinical isolates of Candida spp. and other yeasts.

Journal of clinical microbiology·2009
Same journal

The Evidence Is In: Devices and Biologics Reshaping Modern Dermatology.

Dermatologic clinics·2026
Same journal

Energy-Based Devices for Body Contouring.

Dermatologic clinics·2026
Same journal

Microfocused Ultrasound with Visualization for Skin Tightening: Clinical Applications, Safety, and Technical Considerations.

Dermatologic clinics·2026
Same journal

Devices in Onychomycosis: A Status Update.

Dermatologic clinics·2026
Same journal

Acne Laser Devices in Dermatology.

Dermatologic clinics·2026
Same journal

Fractional Laser Therapy for Androgenetic Alopecia: Mechanisms, Clinical Evidence, and Practical Implementation.

Dermatologic clinics·2026
See all related articles

Area of Science:

  • Medical Mycology
  • Dermatology

Background:

  • Mycoses caused by dematiaceous (darkly pigmented) fungi are increasing in clinical significance.
  • These fungal infections, termed phaeohyphomycosis, are a growing concern for dermatologists.

Purpose of the Study:

  • To highlight the escalating issue of phaeohyphomycosis.
  • To outline optimal management strategies for dematiaceous fungal infections.

Main Methods:

  • Review of clinical and laboratory presentations.
  • Emphasis on mycologic diagnostic approaches.
  • Discussion of current therapeutic modalities, including surgical and chemotherapeutic options.

Main Results:

  • Phaeohyphomycosis presents unique challenges in diagnosis and treatment.

Related Experiment Videos

  • Effective management hinges on a high index of suspicion and comprehensive mycologic evaluation.

    • Conclusions:

    • Optimal management of phaeohyphomycosis requires a multidisciplinary approach.
    • Integrating clinical knowledge, laboratory findings, and therapeutic awareness is crucial for patient outcomes.